Know What's Happening in Healthcare

Today's Healthcare Pulse

Allogene Therapeutics CEO David Chang to step down

Allogene Therapeutics announced that chief executive David Chang will leave his role. The news was reported by STAT+ and echoed in a follow‑up piece covering broader pharma updates.

INOVAIT Announces Innovation Award Winners
NewsFeb 18, 2026

INOVAIT Announces Innovation Award Winners

INOVAIT announced the 2025/26 award winners at its Ottawa meeting, honoring Altis Labs with the Maple Leaf Award for AI imaging collaborations, Nova Scotia Health with the Aurora Borealis Award for industry‑academic synergy, and Profound Medical with the Mount Logan...

By Canadian Healthcare Technology
NWT Looks at Acquiring MRI Scanner
NewsFeb 18, 2026

NWT Looks at Acquiring MRI Scanner

The Northwest Territories is conducting a feasibility study to install an MRI scanner at Yellowknife’s Stanton Territorial Hospital, aiming to end the practice of sending patients to Alberta for scans. Health Minister Lesa Semmler highlighted that the study will assess...

By Canadian Healthcare Technology
Infoway Pulls the Plug on PrescribeIT
NewsFeb 18, 2026

Infoway Pulls the Plug on PrescribeIT

Canada Health Infoway announced that its e‑prescribing platform PrescribeIT will be discontinued on May 29, ending a program that has cost more than $250 million since its 2017 launch. The service never achieved scale, with fewer than 5 percent of prescriptions routed through...

By Canadian Healthcare Technology
Bausch + Lomb Corp (BLCO) Q4 2025 Earnings Call Transcript
NewsFeb 18, 2026

Bausch + Lomb Corp (BLCO) Q4 2025 Earnings Call Transcript

Glaukos Corp reported record fourth‑quarter 2025 sales of $143.1 million, a 36% year‑over‑year increase, and annual net sales of $507.4 million, up 32%. The company reaffirmed its 2026 revenue outlook of $600‑$620 million, indicating more than 20% growth. Growth was powered by the...

By Motley Fool – Earnings Transcripts
Sex Differences in Placebo and Antidepressant Response to Intranasal Esketamine for Treatment-Resistant Depression
NewsFeb 18, 2026

Sex Differences in Placebo and Antidepressant Response to Intranasal Esketamine for Treatment-Resistant Depression

A pooled analysis of five double‑blind, placebo‑controlled intranasal esketamine trials (n≈1,016) confirms that esketamine significantly reduces Montgomery‑Åsberg Depression Rating Scale (MADRS) scores versus placebo. Female participants showed larger total MADRS improvements at later visits (days 22 and 28) and greater reductions in...

By Nature (Biotechnology)
Community Health Systems Inc (CYH) Q4 2025 Earnings Call Transcript
NewsFeb 18, 2026

Community Health Systems Inc (CYH) Q4 2025 Earnings Call Transcript

Community Health Systems reported a 2.1% year‑over‑year increase in same‑store net revenue for Q4 2025, driven by rate growth and higher acuity, while adjusted EBITDA reached $395 million with a 12.7% margin. The company continued its aggressive deleveraging, cutting net leverage...

By Motley Fool – Earnings Transcripts
Insulet Corp (PODD) Q4 2025 Earnings Call Transcript
NewsFeb 18, 2026

Insulet Corp (PODD) Q4 2025 Earnings Call Transcript

Inspire Medical Systems reported a strong fourth‑quarter, with revenue rising 12% to $269 million and full‑year sales up 14% to $912 million, driven by existing and new center growth. The company set 2026 revenue guidance between $950 million and $1 billion, reflecting a 4%‑10%...

By Motley Fool – Earnings Transcripts
Ocular and Upstream Drop on Less-than-Wow Data; Compass Rallies on Second Phase III Win for Psilocybin
NewsFeb 17, 2026

Ocular and Upstream Drop on Less-than-Wow Data; Compass Rallies on Second Phase III Win for Psilocybin

Ocular Therapeutix reported that its VEGF1/2/3 inhibitor Axpaxli outperformed aflibercept in the Phase III SOL‑1 trial, with 74.1% of patients maintaining visual acuity at 36 weeks versus 55.8% for the comparator. The study also met a 52‑week durability endpoint, showing 65.9%...

By BioCentury
STAT+: At Drugmakers’ Forum, Oz Gets a Friendly Embrace, While Makary Faces Tough Questions
NewsFeb 17, 2026

STAT+: At Drugmakers’ Forum, Oz Gets a Friendly Embrace, While Makary Faces Tough Questions

At a PhRMA‑hosted forum, CMS Administrator Mehmet Oz engaged warmly with Pfizer CEO Albert Bourla, championing vaccines and proposing closed‑door policy talks and even suggesting industry executives consider government jobs. In contrast, FDA Commissioner Marty Makary was sharply questioned by...

By STAT News — Pharma
Induction Cooktops Safe for Pacemakers with Proper Awareness
SocialFeb 17, 2026

Induction Cooktops Safe for Pacemakers with Proper Awareness

Are induction cooktops dangerous for people with pacemakers? In rare cases, magnets can interfere with heart devices, but typically only when held extremely close. That doesn’t mean the technology is dangerous. It means awareness matters. Modern shielding + thoughtful device placement significantly reduce...

By Ami Bhatt, MD
Oral SERD Spotlight. Plus: Setbacks at FDA— a BioCentury Podcast
NewsFeb 17, 2026

Oral SERD Spotlight. Plus: Setbacks at FDA— a BioCentury Podcast

The BioCentury This Week podcast highlighted the rapid expansion of oral selective estrogen receptor degraders (SERDs) as a leading application of targeted protein degradation, noting several candidates advancing toward late‑stage trials. Host Lauren Martz examined the competitive landscape and the therapeutic...

By BioCentury
State Bills Target Nursing Home Transparency, Staffing and CNA Funding
NewsFeb 17, 2026

State Bills Target Nursing Home Transparency, Staffing and CNA Funding

Virginia lawmakers are debating a suite of bills aimed at improving nursing home oversight, staffing, and transparency. One proposal sets minimum nursing care hours at 3.08 per resident per day through 2027, rising to 3.25 by 2031 for facilities in...

By Skilled Nursing News
‘We’re Not Through’: More Hybrid QM Data Collection Likely Ahead for Nursing Homes
NewsFeb 17, 2026

‘We’re Not Through’: More Hybrid QM Data Collection Likely Ahead for Nursing Homes

The Centers for Medicare & Medicaid Services (CMS) is expanding its hybrid quality‑measure (QM) methodology, merging Minimum Data Set (MDS) information with Medicare claims to improve accuracy. Recent OIG reports on antipsychotic medication use and falls with major injury prompted...

By Skilled Nursing News
Judge’s Ruling Expected On Whether To Block ACIP Meeting
NewsFeb 17, 2026

Judge’s Ruling Expected On Whether To Block ACIP Meeting

A federal judge is set to rule this week on a lawsuit seeking to prevent the CDC’s Advisory Committee on Immunization Practices (ACIP) from convening. The plaintiffs argue the committee, whose members were appointed by HHS Secretary Robert F. Kennedy...

By Inside Health Policy
Rhododendron-Derived Drugs Now Made by Bacteria
NewsFeb 17, 2026

Rhododendron-Derived Drugs Now Made by Bacteria

Kobe University bioengineers have re‑programmed the gut bacterium Escherichia coli to synthesize orsellinic acid, the core of Rhododendron‑derived meroterpenoids, at 202 mg per liter—a 40‑fold increase over prior microbial attempts. This marks the first time the complex eukaryotic pathway has been...

By Phys.org – Biotechnology
Hospitals Mount Response as Site-Neutral Payment Policy Progresses
NewsFeb 17, 2026

Hospitals Mount Response as Site-Neutral Payment Policy Progresses

Hospital groups warn that expanding site‑neutral Medicare payment could slash revenues by $182 billion over the next decade, with rural facilities facing a $26.3 billion hit. The FTI Consulting report, commissioned by the Coalition to Strengthen America’s Healthcare, projects an 8% cut...

By HFMA – Healthcare Financial Management Association
Doctors Tell Senators CMS Red Tape Is Driving Workforce Exodus, Threatening Access
NewsFeb 17, 2026

Doctors Tell Senators CMS Red Tape Is Driving Workforce Exodus, Threatening Access

Physicians, medical educators and health system leaders testified before the Senate Special Committee on Aging that escalating CMS regulations—particularly prior authorizations and Medicare quality reporting—are intensifying burnout and prompting many to leave clinical practice. The testimony highlighted that these administrative...

By Inside Health Policy
FDA to End GRAS Loophole, Track Thousands of Additives
SocialFeb 17, 2026

FDA to End GRAS Loophole, Track Thousands of Additives

This is a big deal. Since 1958, the FDA has allowed food companies to self-certify ingredients as "Generally Recognized As Safe" (GRAS). In comparison Europe only allows ~400 such additives to their foods. In the US there are 4,000–10,000 ingredients that are added...

By Robert Lufkin, MD
AI-Powered MRI Evaluations Predict STEMI Outcomes Better than Existing Risk Scores
NewsFeb 17, 2026

AI-Powered MRI Evaluations Predict STEMI Outcomes Better than Existing Risk Scores

A machine‑learning model that combines cardiac MRI data with clinical variables predicts long‑term major adverse cardiovascular events (MACE) in STEMI patients more accurately than the GRACE and TIMI scores. The study analyzed 1,066 patients, training on 682 cases and testing...

By Cardiovascular Business
From Sensors to Smart Systems: The Rise of AI-Driven Photonic Noses
NewsFeb 17, 2026

From Sensors to Smart Systems: The Rise of AI-Driven Photonic Noses

The 2025 review in *Microsystems & Nanoengineering* details how photonic noses combine optical sensing with AI to create highly selective, drift‑free chemical detectors. By leveraging colorimetric, refractive‑index, absorption and spectroscopy techniques, these devices generate rich spectral fingerprints that machine‑learning models...

By Nanotech Now
Projecting Light to Dispense Liquids: A New Route to Ultra-Precise Microdroplets
NewsFeb 17, 2026

Projecting Light to Dispense Liquids: A New Route to Ultra-Precise Microdroplets

Researchers at Southern University of Science and Technology have unveiled an optoelectrowetting platform that uses programmable light patterns to dispense nanoliter droplets with unprecedented precision. By projecting dynamic illumination onto a microfluidic chip, the system creates virtual electrodes that guide...

By Nanotech Now
Gilead-Genhouse Tie-Up Among Several Spanning Pacific: Deals Report
NewsFeb 17, 2026

Gilead-Genhouse Tie-Up Among Several Spanning Pacific: Deals Report

Gilead Sciences has agreed to pay $80 million upfront to Suzhou Genhouse Bio for worldwide rights to GH31, a clinic‑ready oncology molecule. GH31 employs synthetic lethality to inhibit the MAT2A enzyme, a target implicated in several cancers. The deal follows regulatory...

By BioCentury
Hidden Insurance Costs in Healthcare
BlogFeb 17, 2026

Hidden Insurance Costs in Healthcare

The article highlights hidden insurance risk from undertrained nursing assistants and home caregivers, linking credential gaps to higher workers' compensation, liability, and long‑term care costs. It argues insurers should treat frontline training as loss‑mitigation, incentivizing certifications and first‑aid programs. By...

By Insurance Thought Leadership (ITL)
Kolchinsky: Policy Constraints Holding Back Biomedical Innovation
NewsFeb 17, 2026

Kolchinsky: Policy Constraints Holding Back Biomedical Innovation

In a BioCentury interview, RA Capital Managing Partner Peter Kolchinsky warned that staffing cuts and a growing conservative stance at the FDA are adding at least a three‑month delay to even the most promising drug programs. He says sponsors are now...

By BioCentury
Pancreatic Cancer Cells Sense ECM to Switch Between Growth and Autophagy
NewsFeb 17, 2026

Pancreatic Cancer Cells Sense ECM to Switch Between Growth and Autophagy

Researchers at NYU Langone Health discovered that pancreatic ductal adenocarcinoma cells sense extracellular matrix (ECM) components via the surface protein integrin α3, which determines whether they adopt a proliferative or autophagic state. Cells anchored to laminin‑rich ECM keep autophagy low and...

By GEN (Genetic Engineering & Biotechnology News)
Resources for Biomarker Requestors
NewsFeb 17, 2026

Resources for Biomarker Requestors

The FDA’s Biomarker Qualification Program (BQP) offers a three‑stage pathway—Letter of Intent, Qualification Plan, and Full Qualification Package—to secure regulatory endorsement of biomarkers as drug development tools. Under the 21st Century Cures Act, the process has been modernized, allowing qualified...

By FDA
Deprescribing in Health Care: Why Less Medication Can Be More
BlogFeb 17, 2026

Deprescribing in Health Care: Why Less Medication Can Be More

The American Medical Association is urging clinicians to adopt deprescribing—systematically reviewing and stopping medications that no longer benefit patients. Nearly 70% of adults aged 40‑79 fill a prescription each month, and over 20% take five or more drugs, driving falls,...

By KevinMD
Autonomous Wheelchair Maps Home, Yet Cost Hurdles Remain
SocialFeb 17, 2026

Autonomous Wheelchair Maps Home, Yet Cost Hurdles Remain

What if your wheelchair could map your house and drive you to specific spots on command? Strutt's EV1 does exactly that. It learns your space, lets you save waypoints, and navigates at 3 mph while avoiding obstacles. Manual override is...

By IEEE Spectrum Threads
Enlil Launches Milestone View for Its Medtech Product Lifecycle Traceability Software
NewsFeb 17, 2026

Enlil Launches Milestone View for Its Medtech Product Lifecycle Traceability Software

Enlil unveiled Milestone View, the industry’s first evidence‑based milestone interface for medical device product development. The new capability embeds directly within Enlil’s unified traceability platform, linking each milestone to underlying requirements, design outputs, risk controls, change histories and regulatory evidence....

By Medical Design & Outsourcing
Timing Is Critical when Using Ultrasound for Pediatric UTI Cases
NewsFeb 17, 2026

Timing Is Critical when Using Ultrasound for Pediatric UTI Cases

New research from the Advocate Aurora Research Institute suggests that the timing of renal and bladder ultrasounds in hospitalized infants and young children with febrile urinary tract infections (UTIs) significantly affects diagnostic accuracy. Ultrasounds performed within 24 hours of the last...

By Radiology Business
PCCI CEO Steve Miff on the 4 Pillars of a Trustworthy AI Framework
NewsFeb 17, 2026

PCCI CEO Steve Miff on the 4 Pillars of a Trustworthy AI Framework

Parkland Center for Clinical Innovation (PCCI) unveiled a four‑pillar framework—prediction transparency, performance transparency, security transparency, and compliance—to ensure trustworthy AI throughout model lifecycles. The framework underpins 14 production models and several in testing, supported by tools like the Islet visualizer...

By Healthcare Innovation
99% Accuracy, 75% Less Manual Work: Inside One Hospice’s HOPE Secret Weapon
NewsFeb 17, 2026

99% Accuracy, 75% Less Manual Work: Inside One Hospice’s HOPE Secret Weapon

Anchor Health, a California hospice provider, adopted Vitalis’s Ray tool to meet the Medicare‑mandated HOPE compliance requirements. Ray pulls real‑time data from the HOPE dashboard, delivering roughly 99% accuracy while cutting manual tracking effort by about 75%. In a pilot,...

By Hospice News
Court Rules Medicare Compliance No Defense Against OSHA Workplace Violence Citations
NewsFeb 17, 2026

Court Rules Medicare Compliance No Defense Against OSHA Workplace Violence Citations

A Tenth Circuit Court of Appeals decision rejected Cedar Springs Hospital's claim that Medicare compliance shields it from OSHA workplace‑violence citations. The Colorado psychiatric facility was cited for seven safety deficiencies and fined $13,494. The court clarified that CMS regulations...

By HRD (Human Capital Magazine) US
What the Folinic Acid Retraction Means for Autism Treatment
BlogFeb 17, 2026

What the Folinic Acid Retraction Means for Autism Treatment

The European Journal of Pediatrics retracted the 2024 randomized trial that claimed folinic acid reduced autism symptoms, citing data that did not support its conclusions. The study had been the largest of its kind, influencing clinical recommendations and regulatory guidance....

By KevinMD
Pinterest and Maven Team up to Provide Menopause Support to Employees
NewsFeb 17, 2026

Pinterest and Maven Team up to Provide Menopause Support to Employees

Pinterest has partnered with Maven Clinic to launch a unified menopause, fertility and parenting support platform for its workforce. The initiative aims to curb the $1.8 billion productivity loss attributed to menopause‑related disruptions in 2023. By consolidating care into a single...

By Employee Benefit News
Transforming Patient Care: The Role of AI and Data Literacy in a New Era
NewsFeb 17, 2026

Transforming Patient Care: The Role of AI and Data Literacy in a New Era

FINN Partners released an eBook titled “Human‑First Health Information,” arguing that healthcare is moving beyond static electronic health records to AI‑driven, adaptive tools. The authors claim AI can cut clinician workload, personalize treatment, and turn massive data streams into actionable...

By Healthcare Innovation
Key Obstacle to Integrated Bioelectronic Implants Removed with Use of Solid-State Hydrogel
BlogFeb 17, 2026

Key Obstacle to Integrated Bioelectronic Implants Removed with Use of Solid-State Hydrogel

Swedish researchers have created a photo‑patternable solid‑state hydrogel electrolyte using i‑carrageenan and PEGDA, achieving ionic conductivity above 10 mS cm⁻¹ and feature sizes down to 15 µm. The material replaces liquid electrolytes in organic electrochemical transistors (OECTs), enabling fast, dense, and flexible circuits...

By FrogHeart
The Aging of Retinal Vasculature Reflects the Aging of the Brain
BlogFeb 17, 2026

The Aging of Retinal Vasculature Reflects the Aging of the Brain

Researchers used UK Biobank data to map vascular phenotypes across the retina, carotid artery, aorta, and brain, revealing consistent cross‑organ correlations. Retinal vascular density showed modest but significant negative links with white‑matter hyperintensities, carotid intima‑media thickness, and aortic lumen size,...

By Fight Aging!
Choice Health at Home Acquires Alliant Home Health, Palliative Care, Hospice
NewsFeb 17, 2026

Choice Health at Home Acquires Alliant Home Health, Palliative Care, Hospice

Choice Health at Home announced the acquisition of Alliant Home Health, Alliant Palliative Care, and Alliant Hospice, extending its service portfolio in Colorado. The deal, closed on November 12, 2025, adds occupational and physical therapy, skilled nursing, and hospice services...

By Hospice News
How Magnetic Interactions Between Neighboring Nanoparticles Influence MRI Contrast
BlogFeb 17, 2026

How Magnetic Interactions Between Neighboring Nanoparticles Influence MRI Contrast

Researchers at the Institute of Nanoscience and Materials (INL) demonstrated that precisely controlling the distance between iron‑oxide nanoparticles using silica shells dramatically alters their magnetic dipolar interactions, boosting T2 MRI contrast. The study shows a rapid increase in contrast as...

By Nanowerk
GLP‑1 Therapies Improve Metabolism Beyond Weight Loss
SocialFeb 17, 2026

GLP‑1 Therapies Improve Metabolism Beyond Weight Loss

Incretin (GLP-1) based therapies have dramatic effects on many aspects of metabolic disease. Can this occur independent of the effect on obesity? https://www.nature.com/articles/s44324-024-00030-5

By Robert Lufkin, MD
EHR Export Docs Reviewed: Gaps, Wins, and Fixes
SocialFeb 17, 2026

EHR Export Docs Reviewed: Gaps, Wins, and Fixes

I analyzed the mandatory "EHI Export" documentation for essentially every certified EHR on the market. Read on for the full picture; examples of the good, the bad, and the ugly; and recommendations for ONC, vendors, and patients to improve access...

By Josh Mandel, MD
The Payload Paradox: Why the Obsession with Potency May Be Holding the ADC Field Back
BlogFeb 17, 2026

The Payload Paradox: Why the Obsession with Potency May Be Holding the ADC Field Back

A European biotech is challenging the ADC status quo by prioritising novel targets and payloads over sheer potency. In an interview, the company’s CSO argues that the industry’s obsession with ultra‑potent cytotoxins like MMAE and DM1 is stalling progress, creating...

By Biotech Strategy Blog
AI Powers Scalable, Health‑literate Content Revisions
SocialFeb 17, 2026

AI Powers Scalable, Health‑literate Content Revisions

Healthcare organizations already have content. The challenge is reviewing and improving it at scale. Fred Camacho, PhD (HealthcareGPS) explains how AI enables human-in-the-loop health-literate revisions.👇 https://t.co/0iieGLgaNc @HealthcareGPSai #IHA #HealthLiteracy #HITSM https://t.co/c0GsWP93Uj

By Colin Hung
Get AI Medical Second Opinions by Photo or Upload
SocialFeb 17, 2026

Get AI Medical Second Opinions by Photo or Upload

You can just take a picture of your medical data or upload the file to get a second opinion from Grok

By Elon Musk
Turning Microalgae-Derived Extracellular Vesicles Into a Next-Generation Drug Delivery Platform
NewsFeb 17, 2026

Turning Microalgae-Derived Extracellular Vesicles Into a Next-Generation Drug Delivery Platform

Paris‑based AGS Therapeutics signed a strategic agreement with INITS SMO, a GMP‑qualified shared manufacturing organization, to transition its microalgae‑derived extracellular vesicle (MEV) platform to full GMP compliance. The partnership allows AGS to run its proprietary MEV manufacturing, loading, and analytics...

By GEN (Genetic Engineering & Biotechnology News)
Blood Test Maps Organ Age for Early Intervention
SocialFeb 17, 2026

Blood Test Maps Organ Age for Early Intervention

.@Vero_Bioscience is working to end age related chronic disease. With a simple blood test, Vero uses proteomics and machine learning to measure the biological age of each organ, revealing where the body is aging fastest so people can intervene early...

By Vinod Khosla
European ADC Agents with Novel Targets Gain Momentum
SocialFeb 17, 2026

European ADC Agents with Novel Targets Gain Momentum

With all the attention on China for TOPO-I ADCs of late, how about the potential for European agents, especially ones involving novel targets? Our latest expert interview drops with some hard hitting and candid opinions from a battle hardened...

By Sally Church
Value-Based Care Data Gap: Why Metrics Fail to Reach the Bedside
BlogFeb 17, 2026

Value-Based Care Data Gap: Why Metrics Fail to Reach the Bedside

Value‑based care aims to align reimbursement with patient outcomes, but the data that drives these models rarely reaches clinicians at the point of care. Performance metrics are collected in dashboards and quarterly reports, creating a disconnect between institutional goals and...

By KevinMD